RedShiftBio Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Series F

  • Latest Deal Amount
  • $5.91M

  • Investors
  • 5

RedShiftBio General Information

Description

Developer of bioanalytical instrumentation designed to transform protein characterization. The company's tools combine laser, microfluidics, and analytical technologies for the development of protein therapeutic drugs, as well as the measurement of protein-based drug therapies, enabling scientists to detect and monitor protein conformation and conduct label-free protein analysis.

Contact Information

Formerly Known As
RedShift Systems
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 80 Central Street
  • Boxborough, MA 01719
  • United States
+1 (781)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Biotechnology
Corporate Office
  • 80 Central Street
  • Boxborough, MA 01719
  • United States
+1 (781)

RedShiftBio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RedShiftBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC (Series F) 25-Jun-2025 $5.91M Completed Generating Revenue
13. Debt - General 24-Jul-2024 Completed Generating Revenue
12. Later Stage VC (Series E) 21-Mar-2024 Completed Generating Revenue
11. Mezzanine 23-Mar-2022 Completed Generating Revenue
10. Secondary Transaction - Private 01-May-2021 Completed Generating Revenue
9. Later Stage VC (Series D) 23-Dec-2020 Completed Generating Revenue
8. Debt - PPP 12-Apr-2020 Completed Generating Revenue
7. Secondary Transaction - Private 01-Jul-2018 Completed Startup
6. Later Stage VC (Series C) 08-Mar-2017 $10.8M $38.8M Completed Startup
5. Later Stage VC (Series B) 02-Oct-2015 $4.75M $28M Completed Startup
To view RedShiftBio’s complete valuation and funding history, request access »

RedShiftBio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series F
Series E
Series D
Series C
Series B 52,729,331 $0.001000 8% $0.18 $0.18 1x $0.18 12.61%
Series A1 10,401,838 $0.001000 8% $0.31 $0.31 1x $0.31 2.49%
To view RedShiftBio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

RedShiftBio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of bioanalytical instrumentation designed to transform protein characterization. The company's tools combine l
Discovery Tools (Healthcare)
Boxborough, MA
27 As of 2026

Cambridge, United Kingdom
 

Zurich, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

RedShiftBio Competitors (18)

One of RedShiftBio’s 18 competitors is Sphere Fluidics, a Formerly VC-backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sphere Fluidics Formerly VC-backed Cambridge, United Kingdom
Biognosys Formerly VC-backed Zurich, Switzerland
Nanion Technologies Accelerator/Incubator Backed Munich, Germany
Preomics Venture Capital-Backed Munich, Germany
MOBILion Systems Formerly VC-backed Chadds Ford, PA
You’re viewing 5 of 18 competitors. Get the full list »

RedShiftBio Patents

RedShiftBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260140051-A1 Infrared transmission flow cell with thermal ramping capability Pending 18-Nov-2024
WO-2026107480-A1 Infrared transmission flow cell with thermal ramping capability Pending 18-Nov-2024
US-20250264406-A1 Infrared transmission cell with attached flow sensor for microfluidic modulation spectroscopy Pending 21-Feb-2024
WO-2025179173-A1 Infrared transmission cell with attached flow sensor for microfluidic modulation spectroscopy Pending 21-Feb-2024
EP-4710092-A1 Matched optical filter Pending 12-May-2023 G01N21/3577
To view RedShiftBio’s complete patent history, request access »

RedShiftBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RedShiftBio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Illumina Ventures Venture Capital Minority
Hercules Capital (San Mateo) Lender/Debt Provider Minority
Angel (individual) Minority
Waters Corporation Minority
Technology Venture Partners (US) Venture Capital Minority
To view RedShiftBio’s complete investors history, request access »

RedShiftBio FAQs

  • When was RedShiftBio founded?

    RedShiftBio was founded in 2005.

  • Where is RedShiftBio headquartered?

    RedShiftBio is headquartered in Boxborough, MA.

  • What is the size of RedShiftBio?

    RedShiftBio has 27 total employees.

  • What industry is RedShiftBio in?

    RedShiftBio’s primary industry is Discovery Tools (Healthcare).

  • Is RedShiftBio a private or public company?

    RedShiftBio is a Private company.

  • What is the current valuation of RedShiftBio?

    The current valuation of RedShiftBio is .

  • What is RedShiftBio’s current revenue?

    The current revenue for RedShiftBio is .

  • How much funding has RedShiftBio raised over time?

    RedShiftBio has raised $101M.

  • Who are RedShiftBio’s investors?

    Illumina Ventures, Hercules Capital (San Mateo), , Waters, and Technology Venture Partners (US) have invested in RedShiftBio.

  • Who are RedShiftBio’s competitors?

    Sphere Fluidics, Biognosys, Nanion Technologies, Preomics, and MOBILion Systems are some of the 18 competitors of RedShiftBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process